Zobrazeno 1 - 10
of 1 311
pro vyhledávání: '"E. Leo"'
Publikováno v:
Revista Espanola de Enfermedades Digestivas, Vol 100, Iss 8, Pp 466-469 (2008)
Objetivo: comparar dos pautas de pantoprazol por vía intravenosa en pacientes con hemorragia digestiva alta (HDA) ulcerosa de alto riesgo para presentar persistencia o recidiva hemorrágica. Material y método: se randomizaron los pacientes en dos g
Externí odkaz:
https://doaj.org/article/5958720149554f84a23dfab5ec106530
Publikováno v:
Revista Espanola de Enfermedades Digestivas, Vol 99, Iss 5, Pp 275-279 (2007)
Objetivos: analizar la evolución, a lo largo del periodo 1999-2005, de las siguientes variables de los pacientes ingresados por hemorragia digestiva (HD) en una Unidad de Sangrantes: etiología, patología de base, consumo de AINE/anticoagulación y
Externí odkaz:
https://doaj.org/article/a63ea0fdffcb40e58e0d7ccc4c460c75
Publikováno v:
Revista Espanola de Enfermedades Digestivas, Vol 98, Iss 10, Pp 760-769 (2006)
Objectives: 1. To study transfusion requirements in the Department of Gastroenterology of a Tertiary Referral Hospital, and their evolution over the last seven years. 2. To analyze risk factors associated with greater erythrocyte transfusion requirem
Externí odkaz:
https://doaj.org/article/52a4b48020d846b08ebcf65cf0aeaf7e
Publikováno v:
Microbiologia Medica, Vol 22, Iss 3 (2007)
Externí odkaz:
https://doaj.org/article/f3622ec2fd824e0a88b0e172ce7552d9
Publikováno v:
Microbiologia Medica, Vol 22, Iss 3 (2007)
Externí odkaz:
https://doaj.org/article/668a2d1020bd4a48a8b936bab00f17d6
Publikováno v:
Revista Espanola de Enfermedades Digestivas, Vol 100, Iss 8, Pp 466-469
Objetivo: comparar dos pautas de pantoprazol por vía intravenosa en pacientes con hemorragia digestiva alta (HDA) ulcerosa de alto riesgo para presentar persistencia o recidiva hemorrágica. Material y método: se randomizaron los pacientes en dos g
Externí odkaz:
https://doaj.org/article/e9bc0d35c73146b986086977794803b9
Publikováno v:
Revista Espanola de Enfermedades Digestivas, Vol 98, Iss 10, Pp 760-769
Objectives: 1. To study transfusion requirements in the Department of Gastroenterology of a Tertiary Referral Hospital, and their evolution over the last seven years. 2. To analyze risk factors associated with greater erythrocyte transfusion requirem
Externí odkaz:
https://doaj.org/article/1e9ea57cdab9463988e7441c8cbbbfd4
Autor:
M Chaparro, M García Donday, S Riestra, A J Lucendo, J M Benítez, M Navarro-Llavat, J Barrio, V J Morales-Alvarado, M Rivero, D Busquets, E Leo Carnerero, O Merino Ochoa, O Nantes Castillejo, P Navarro, M Van Domselaar, A Gutiérrez Casbas, I Alonso-Abreu, R Mejuto, L Fernández Salazar, M Iborra, M D Martín-Arranz, J R Pineda, M J Sampedro, K Serra Nilsson, A Bouhmidi Assakali, L Batista, C Muñoz Villafranca, I Rodríguez-Lago, D S Ceballos Santos, I Guerra, M Mañosa, I Marín Jimenez, I Vera Mendoza, M Barreiro-de Acosta, E Domènech, M Esteve, V García-Sánchez, P Nos, J Panés, J P Gisbert
Publikováno v:
Journal of Crohn's and Colitis. 17:i50-i54
Background Background: The feasibility of anti-TNF discontinuation in inflammatory bowel disease (IBD) must be proven in clinical trials including patients in clinical, endoscopic, and radiologic remission at the time of anti-TNF withdrawal to make r
Autor:
M Chaparro, D Acosta, C Rodríguez, F Mesonero, M Vicuña, M Barreiro-de Acosta, A Fernández-Clotet, Á Hernández Martínez, M Arroyo, I Vera, A Ruiz-Cerulla, B Sicilia, M J Cabello Tapia, C Muñoz Villafranca, J Castro-Poceiro, J Martínez Cadilla, M Sierra-Ausín, J M Vázquez Morón, E Montil Miguel, F Bermejo, V Royo, M Calafat, C González-Muñoza, E Leo Carnerero, N Manceñido Marcos, L Torrealba, H Alonso-Galán, J M Benítez, Y Ber Nieto, M T Diz-Lois Palomares, M J García, J F Muñoz, E M Armesto González, X Calvet, A Hernández-Camba, R E Madrigal Domínguez, L Menchén, J L Pérez Calle, M Piqueras, J P Gisbert
Publikováno v:
Journal of Crohn's and Colitis. 17:i806-i808
Background Main aim: To assess the durability of tofacitinib treatment in patients with ulcerative colitis (UC). Secondary aims: To assess the short and long-term effectiveness; the tolerability of tofacitinib in clinical practice; and to evaluate th
Autor:
C Rubín De Célix, J Martín de Carpi, G Pujol, L Palomino, M Velasco, R Martín-Masot, V M Navas-López, E Ricart, M J Casanova, A Rodríguez Martínez, E Leo, A Alcaraz, M Mañosa, V Hernández, R Fernández, C Sánchez, L Menchén, F Mesonero, M Barreiro-De Acosta, N Martinon, C Tejido Sandoval, A Rendo Vázquez, P Corsino, R Vicente, A Hernández-Camba, J R Alberto Alonso, I Alonso-Abreu, A M Castro Millán, L Peries Reverter, B Castro, E Fernández-Salgado, M M Busto Cuiñas, J M Benítez, L Madero, F Clemente, S Riestra, S Jiménez-Treviño, M Boscá, M Chaparro, J P Gisbert
Publikováno v:
Journal of Crohn's and Colitis. 17:i37-i39
Background It has been suggested that the transition of patients from paediatric to adult care units may be key in the outcomes of inflammatory bowel disease (IBD). However, the impact of transition in real clinical practice has been barely studied.